Six-Year Follow-Up Clinical Study on HOYA Vision Care’s MiYOSMART Spectacle Lens to Be Presented at ARVO 2022

The first long-term effects of DIMS spectacle lens on myopia progression will be shared

Bangkok – 20 April 2022 – HOYA Vision Care, a leader in optical technology innovation, today announced that Professor Carly Lam from the Centre for Myopia Research at The Hong Kong Polytechnic University will present the findings of a six-year follow-up clinical study they conducted on the MiYOSMART spectacle lens with Defocus Incorporated Multiple Segments (D.I.M.S.) Technology to reduce myopia progression in children. The findings, of the longest running study on a myopia management spectacle lens, will be shared during the Association for Research in Vision and Ophthalmology (ARVO) 2022 conference to be held from May 1-4 in Denver, Colorado, USA.

The presentation will include highlights of the six-year clinical study conducted by researchers at the Hong Kong Polytechnic University which looks at the progression of myopia in children who wore the HOYA Vision Care’s MiYOSMART spectacle lens. This information will enhance a previous three-year follow-up study1, a continuation of a two-year randomized control trial (RCT)2, which was published in the British Journal of Ophthalmology and that demonstrated strong evidence of the lenses’ effectiveness in slowing down the progression of myopia in children ages 8-13.1

“This six-year clinical study on the MiYOSMART lens is the longest running study conducted on a myopia management spectacle lens ever, a fact we are very proud of,” said Natalia Vlasak, Ophthalmologist, Global head of Medical and Scientific Affairs at HOYA Vision Care. “Long-term clinical data is essential for evaluating the effectiveness and safety as well as determining possible long-term risks of treatments that can’t be observed during the short period.”

The award winning MiYOSMART lens won the coveted Grand Prize, Grand Award and Gold Medal at the 46th International Exhibition of Inventions of Geneva in April 2018. In October 2020, the spectacle lens won the Silmo d’Or Award in the Vision Category at the Silmo Paris Optical show.


1 Lam CS, Tang WC, Lee PH, et al. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. British Journal of Ophthalmology Published Online First: 17 March 2021. doi: 10.1136/bjophthalmol-2020-317664
2 Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. British Journal of Ophthalmology. Published Online First: 29 May 2019. doi: 10.1136/bjophthalmol-2018-313739
PRODUCT DISCLAIMER – MiYOSMART has not been approved for myopia management in all countries, including the U.S., and is not currently available for sale in all countries, including the U.S.

About HOYA

Founded in 1941 in Tokyo, Japan, HOYA Corporation is a global technology and med-tech company and a leading supplier of innovative high-tech and medical products. HOYA’s divisions and business units research and develop products utilized in the healthcare and information technology fields.

In the healthcare field, we provide medical device products such as eyeglasses, medical endoscopes, contact and intraocular lenses, orthopedic implants, surgical/therapeutic devices and medical device reprocessing and disinfection solutions. In the information technology field, we provide products such as optical lenses, photomasks and blanks used in the manufacturing process for semiconductor and LCD/OLED devices, text to speech, human resources and other software solutions and critical components for the mass memory and cloud storage industries. With over 150 offices and subsidiaries worldwide, HOYA currently employs a multinational workforce of 37,000 people.


About HOYA Vision Care

As a global leader in optical technology, HOYA Vision Care is dedicated to providing innovative vision care solutions for every stage of a patient’s life. A steadfast partner to Eye Care Professionals around the world, it stands at the forefront of optical excellence. With a global presence, consisting of 43 laboratories and a growing team of 20,000 employees, HOYA Vision Care delivers innovative lenses and other vision care solutions to millions of people in 110 countries.

About HOYA

For further information contact: